Showing results (81-90 of 436) with videos related to

Sort By:
Pageof 44
Inflammatory Bowel Diseases|April 2, 2022
Gender-Based Differences in Response to Tumor Necrosis Factor Inhibitor Therapies for Ulcerative Colitis: Individual Participant Data Meta-Analyses of Clinical TrialsManasi Agrawal, Francesca Petralia, Adam Tepler, et al.
Inflammatory Bowel Diseases|September 25, 2025
Anti-TNF Therapies Promote a Proximal-to-Distal Healing Pattern in Moderate-to-Severe Ulcerative ColitisEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Alimentary Pharmacology & Therapeutics|February 15, 2022
Resolution of dominant patient-reported outcome at end of induction predicts clinical and endoscopic remission in Crohn's diseaseEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 27, 2022
Predictors of Placebo Induction Response and Remission in Ulcerative ColitisEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Inflammatory Bowel Diseases|August 3, 2022
Comparative Efficacy of Infliximab vs Ustekinumab for Maintenance of Clinical Response in Biologic Naïve Crohn's DiseaseEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Plos One|May 28, 2020
Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysisJohan Burisch, Wolfgang Eigner, Stefan Schreiber, et al.
Scandinavian Journal of Gastroenterology|August 1, 2022
End of induction patient reported outcomes predict clinical remission and endoscopic improvement with vedolizumab and adalimumab in ulcerative colitisEmily Chu Lee Wong, Badar Hasan, Parambir S Dulai, et al.
Inflammatory Bowel Diseases|November 25, 2022
Predictors of Clinical Remission to Placebo in Clinical Trials of Crohn's DiseaseEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Analytical Chemistry|January 7, 2012
Simultaneous quantification of eleven thiopurine nucleotides by liquid chromatography-tandem mass spectrometryUte Hofmann, Georg Heinkele, Sieglinde Angelberger, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2014
Placebo response rate in clinical trials of fistulizing Crohn's disease: systematic review and meta-analysisAlexander C Ford, Pavit Luthra, Stephen B Hanauer, et al.
Pageof 44